• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Trending
Hamburger Menu Hamburger Menu
  • Biotech
    • Cell & Gene Therapy
    • Clinical Data
    • Venture Capital
    • Deals
  • Research
  • Medtech
    • Devices
    • Diagnostics
    • AI and Machine Learning
  • CRO
  • Special Reports
  • Trending
    • Biologics
    • Clinical Development
    • Ophthalmology
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • CRO Awards
    • Innovation Awards
  • Resources
    • Fierce Events
    • Industry Events
    • Webinars
    • Podcasts
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

chronic pain

Closeup of blue eye on black background
Biotech

Okyo's eye drops reduce neuropathic eye pain in phase 2 win

Pain levels plunged by 5.5 points on a 10-point scale for patients receiving four eye drops a day of Okyo's urcosimod.
Darren Incorvaia Jul 16, 2025 11:57am
Illustration connected puzzle pieces with the acronym MA

Lilly lands next-gen pain asset in $1B SiteOne acquisition

May 27, 2025 11:30am
Beneficial bacteria in gut microbiome

Fecal transplants alleviate fibromyalgia pain in small trial

Apr 28, 2025 7:30am
Gloved hands of jockey prepping saddle on horse

Latigo saddles up with $150M to advance non-opioid pain assets

Mar 17, 2025 5:00am
Graphic showing arrows missing the bullseye on a target

2024's top 10 clinical trial flops

Feb 18, 2025 3:00am
An artists concept of spinal pain A silhouette of a person stands holding their back The spinal cord is highlighted on the

Remedee nabs EU approval for fibromyalgia wristband therapy

Sep 30, 2024 2:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings